Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	p53 binding	HSPD1 NOP53 TEP1 GSK3B BRCA1 MUL1	6.47e-05	77	178	6	GO:0002039
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 PRTG SDK2 DSCAM PCDH20 HMCN2 CELSR2 IGSF9B PLXNB3 CDH16	5.66e-06	187	179	10	GO:0007156
Domain	Ig-like_fold	EPHB6 PRTG SDK2 DSCAM SPEG AZGP1 LRFN3 FNDC5 OBSL1 RELB SIRPB1 KIRREL2 CMYA5 PKHD1L1 SIGLEC15 PXDN HMCN2 CD101 PKHD1 FCRLB IGSF9B SIGLEC1 HCFC2 PLXNB3	8.20e-08	706	180	24	IPR013783
Domain	-	EPHB6 PRTG SDK2 DSCAM SPEG AZGP1 LRFN3 FNDC5 OBSL1 RELB SIRPB1 KIRREL2 CMYA5 PKHD1L1 SIGLEC15 PXDN CD101 PKHD1 FCRLB IGSF9B SIGLEC1 HCFC2 PLXNB3	1.09e-07	663	180	23	2.60.40.10
Domain	Ig_I-set	PRTG SDK2 DSCAM SPEG LRFN3 OBSL1 KIRREL2 PXDN HMCN2 CD101 IGSF9B SIGLEC1	3.25e-07	190	180	12	IPR013098
Domain	I-set	PRTG SDK2 DSCAM SPEG LRFN3 OBSL1 KIRREL2 PXDN HMCN2 CD101 IGSF9B SIGLEC1	3.25e-07	190	180	12	PF07679
Domain	fn3	EPHB6 PRTG SDK2 DSCAM SPEG LRFN3 FNDC5 OBSL1 CMYA5 IGSF9B HCFC2	4.97e-07	162	180	11	PF00041
Domain	FN3	EPHB6 PRTG SDK2 DSCAM SPEG LRFN3 FNDC5 OBSL1 CMYA5 IGSF9B HCFC2	1.85e-06	185	180	11	SM00060
Domain	FN3	EPHB6 PRTG SDK2 DSCAM SPEG LRFN3 FNDC5 OBSL1 CMYA5 IGSF9B HCFC2	3.75e-06	199	180	11	PS50853
Domain	FN3_dom	EPHB6 PRTG SDK2 DSCAM SPEG LRFN3 FNDC5 OBSL1 CMYA5 IGSF9B HCFC2	6.00e-06	209	180	11	IPR003961
Domain	IG	PRTG SDK2 DSCAM SPEG LRFN3 OBSL1 SIRPB1 KIRREL2 SIGLEC15 PXDN HMCN2 CD101 FCRLB IGSF9B SIGLEC1	1.47e-05	421	180	15	SM00409
Domain	Ig_sub	PRTG SDK2 DSCAM SPEG LRFN3 OBSL1 SIRPB1 KIRREL2 SIGLEC15 PXDN HMCN2 CD101 FCRLB IGSF9B SIGLEC1	1.47e-05	421	180	15	IPR003599
Domain	IGc2	PRTG SDK2 DSCAM SPEG LRFN3 OBSL1 KIRREL2 PXDN HMCN2 IGSF9B SIGLEC1	1.81e-05	235	180	11	SM00408
Domain	Ig_sub2	PRTG SDK2 DSCAM SPEG LRFN3 OBSL1 KIRREL2 PXDN HMCN2 IGSF9B SIGLEC1	1.81e-05	235	180	11	IPR003598
Domain	IG_LIKE	PRTG SDK2 DSCAM SPEG AZGP1 LRFN3 OBSL1 SIRPB1 KIRREL2 SIGLEC15 PXDN HMCN2 CD101 FCRLB IGSF9B SIGLEC1	2.28e-05	491	180	16	PS50835
Domain	Ig-like_dom	PRTG SDK2 DSCAM SPEG AZGP1 LRFN3 OBSL1 SIRPB1 KIRREL2 SIGLEC15 PXDN HMCN2 CD101 FCRLB IGSF9B SIGLEC1	3.05e-05	503	180	16	IPR007110
Domain	CH	LRCH1 NAV3 MACF1 UTRN IQGAP3 SMTNL2	3.80e-05	65	180	6	SM00033
Domain	CH	LRCH1 NAV3 MACF1 UTRN IQGAP3 SMTNL2	5.80e-05	70	180	6	PF00307
Domain	-	LRCH1 NAV3 MACF1 UTRN IQGAP3 SMTNL2	6.28e-05	71	180	6	1.10.418.10
Domain	CH	LRCH1 NAV3 MACF1 UTRN IQGAP3 SMTNL2	7.35e-05	73	180	6	PS50021
Domain	CH-domain	LRCH1 NAV3 MACF1 UTRN IQGAP3 SMTNL2	8.56e-05	75	180	6	IPR001715
Domain	IPT	RELB PKHD1L1 PKHD1 PLXNB3	1.23e-04	27	180	4	SM00429
Domain	TIG	RELB PKHD1L1 PKHD1 PLXNB3	2.14e-04	31	180	4	PF01833
Domain	IPT	RELB PKHD1L1 PKHD1 PLXNB3	2.43e-04	32	180	4	IPR002909
Domain	Cul7	CUL9 HERC2	2.75e-04	3	180	2	PF11515
Domain	Flavin_amine_oxidase	MAOB IL4I1	2.75e-04	3	180	2	IPR001613
Domain	CPH_domain	CUL9 HERC2	2.75e-04	3	180	2	IPR021097
Domain	TEX28/TMCC	TMCC1 TEX28	5.47e-04	4	180	2	IPR019394
Domain	Tmemb_cc2	TMCC1 TEX28	5.47e-04	4	180	2	PF10267
Domain	SHR-BD	VPS13A VPS13B	5.47e-04	4	180	2	IPR009543
Domain	G8_domain	PKHD1L1 PKHD1	5.47e-04	4	180	2	IPR019316
Domain	G8	PKHD1L1 PKHD1	5.47e-04	4	180	2	PS51484
Domain	G8	PKHD1L1 PKHD1	5.47e-04	4	180	2	SM01225
Domain	G8	PKHD1L1 PKHD1	5.47e-04	4	180	2	PF10162
Domain	VPS13_C	VPS13A VPS13B	5.47e-04	4	180	2	PF16909
Domain	VPS13_C	VPS13A VPS13B	5.47e-04	4	180	2	IPR031645
Domain	SHR-BD	VPS13A VPS13B	5.47e-04	4	180	2	PF06650
Domain	Autophagy-rel_C	VPS13A VPS13B	9.06e-04	5	180	2	IPR015412
Domain	ATG_C	VPS13A VPS13B	9.06e-04	5	180	2	PF09333
Domain	WW	BAG3 ARHGAP39 HECW2 UTRN	1.08e-03	47	180	4	PF00397
Domain	WW	BAG3 ARHGAP39 HECW2 UTRN	1.17e-03	48	180	4	SM00456
Domain	-	EPPK1 MACF1	1.35e-03	6	180	2	3.90.1290.10
Domain	PbH1	PKHD1L1 PKHD1	1.35e-03	6	180	2	SM00710
Domain	PbH1	PKHD1L1 PKHD1	1.35e-03	6	180	2	IPR006626
Domain	WW_DOMAIN_1	BAG3 ARHGAP39 HECW2 UTRN	1.46e-03	51	180	4	PS01159
Domain	WW_DOMAIN_2	BAG3 ARHGAP39 HECW2 UTRN	1.46e-03	51	180	4	PS50020
Domain	WW_dom	BAG3 ARHGAP39 HECW2 UTRN	1.57e-03	52	180	4	IPR001202
Domain	APC_su10/DOC_dom	CUL9 HERC2	1.88e-03	7	180	2	IPR004939
Domain	Plectin	EPPK1 MACF1	1.88e-03	7	180	2	PF00681
Domain	DOC	CUL9 HERC2	1.88e-03	7	180	2	PS51284
Domain	ANAPC10	CUL9 HERC2	1.88e-03	7	180	2	PF03256
Domain	Plectin_repeat	EPPK1 MACF1	1.88e-03	7	180	2	IPR001101
Domain	APC10	CUL9 HERC2	1.88e-03	7	180	2	SM01337
Domain	PLEC	EPPK1 MACF1	1.88e-03	7	180	2	SM00250
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TMEM94 SPEG OBSL1 CUL9 ARFGEF3 PXDN DOCK7 NAV3 OTUD4 MACF1 MTCL1 RUBCN VPS13B PLXNB3 PLCE1 PDZD2	7.63e-10	407	186	16	12693553
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP36 TANC2 TDRKH PHRF1 LPCAT4 OBSL1 CUL9 ZNF362 SIRPB1 SRCAP TEP1 TUBGCP5 ADH4 HMCN2 BRCA1 ATXN1 SUN2 EPC1 JAZF1 MACF1 SIGLEC1 MTO1 SLC39A7 CDH16	7.95e-09	1116	186	24	31753913
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	HSPD1 DSCAM TBC1D17 SLC3A2 NUP210 DOCK7 PKHD1 ZNF638 PRRC2A IQGAP3	1.54e-07	202	186	10	24639526
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	USP36 TDRKH RBM33 NOP53 ESYT1 PHRF1 RPSA ARHGAP39 WDR43 SLC3A2 MEN1 MRTFB PXDN BRCA1 TPP1 SUN2 OTUD4 MACF1 HCFC2 HERC2 TASOR UTRN PRRC2A IQGAP3 TMCC1	4.80e-07	1497	186	25	31527615
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TANC2 STARD8 COBLL1 ZBTB4 ARHGAP39 TUBGCP5 CRY2 IPO9 SUN2 EEPD1 NUP210 MACF1 TASOR TMCC1	4.93e-07	493	186	14	15368895
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 MGAT4B EPPK1 ZNF628 TMEM94 ESYT1 SPEG ZBTB4 CUL9 FRMD8 RPSA RELB SRCAP TEP1 KIFC2 TBC1D17 LATS2 CELSR2 KIFC3 HERC2 IQGAP3	5.59e-07	1105	186	21	35748872
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	USP36 SDK2 HIVEP1 NOP53 PKD1L1 BAG3 ARFGEF3 HMCN2 MACF1 MTCL1 CPLANE1 PRRC2A	6.45e-07	361	186	12	26167880
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	USP36 RELCH NOP53 BAG3 ZNF362 ARHGAP39 COLGALT1 GSK3B SLC3A2 IPO9 PPM1F SUN2 NUP210 VPS13A ZNF638 OTUD4 NHS HERC2 UTRN PRRC2A	1.01e-06	1049	186	20	27880917
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	HSPD1 USP36 TDRKH ACACB DSCAM NOP53 ESYT1 MUC16 PKHD1L1 SLC3A2 ARFGEF3 BRCA1 VPS13A DOCK7 ZNF638 HCFC2 TASOR	1.09e-06	777	186	17	35844135
Pubmed	Nucleolar exit of RNF8 and BRCA1 in response to DNA damage.	RPSA BRCA1 HERC2	1.49e-06	5	186	3	22814251
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	PRTG DSCAM SPEG LRFN3 OBSL1 KIRREL2 PXDN SIGLEC1	2.82e-06	162	186	8	25826454
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 HIVEP1 ESYT1 COBLL1 BAG3 ARFGEF3 IPO9 NKD2 ATXN1 ARHGEF10 DOCK7 NHS MACF1 MTCL1 TRAPPC14 UTRN TMCC1	4.31e-06	861	186	17	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	GALNT10 DYNC2I1 ZNF362 ARHGAP39 TEP1 OGDH ITFG1 ARFGEF3 MRTFB LATS2 PXDN ATXN1 AOPEP EEPD1 NUP210 ZNF638 AUTS2 MACF1 IGSF9B UTRN TMCC1 VPS13B PDZD2	5.24e-06	1489	186	23	28611215
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	EPHB6 DCHS2 PSAP DSCAM ZNF329 ZBTB4 OBSL1 DYNC2I1 CUL9 CMYA5 TUBGCP5 GTF3C4 ARHGEF10 TPP1 NAV3 MACF1 KIFC3 HERC2 UTRN PRRC2A PLXNB3	5.94e-06	1285	186	21	35914814
Pubmed	HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis.	HSPD1 OBSL1 ARHGEF10 SUN2 UTRN IQGAP3	7.61e-06	87	186	6	33711283
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	HSPD1 RBM33 ESYT1 PIGS ZNF329 LPCAT4 ZNF362 DCLRE1B LRCH1 GTF3C4 SLC3A2 ITFG1 ZNF16 IPO9 NKD2 SUN2 NUP210 DOCK7 AUTS2 SLC39A7	7.83e-06	1203	186	20	29180619
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	USP36 HIVEP1 NOP53 AZGP1 BAG3 OGDH LRRC47 IPO9 BRCA1 ARHGEF10 SUN2 DOCK7 OTUD4 MTCL1 HERC2 UTRN PRRC2A SLC39A7	8.46e-06	1005	186	18	19615732
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	EPPK1 NOP53 PHRF1 CUL9 RPSA WDR43 LRRC47 NUP210 DOCK7 ZNF638 MACF1 HERC2 UTRN PRRC2A	1.26e-05	653	186	14	22586326
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	RBM33 ESYT1 LATS2 NKD2 ZNF638 NHS MACF1 UTRN VPS13B	1.33e-05	263	186	9	34702444
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	ESYT1 PIGS BAG3 OBSL1 GSK3B SLC3A2 LRRC47 ARFGEF3 GJA1 IPO9 PXDN PPM1F NUP210 MUL1 IQGAP3 FAM8A1 CAPN15	1.38e-05	942	186	17	31073040
Pubmed	Biological, clinical and population relevance of 95 loci for blood lipids.	COBLL1 ANKRD55 CELSR2 LPA OSBPL7 DOCK7 MACF1	1.45e-05	146	186	7	20686565
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	A2M EPHB6 NOP53 ESYT1 AZGP1 PHRF1 OBSL1 CUL9 SLC3A2 TPP1 MACF1 PRRC2A	1.65e-05	496	186	12	31343991
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	HIVEP1 ACACB BAG3 PALB2 GTF3C4 MRTFB PPM1F DOCK7 TASOR UTRN SLC39A7	1.73e-05	418	186	11	34709266
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	HSPD1 TDRKH RBM33 NOP53 ESYT1 THUMPD3 OBSL1 DYNC2I1 OGDH WARS2 GSK3B TBC1D17 WDR43 ARFGEF3 SUN2 PTAR1 VPS13A ALAS1 HERC2 MTO1 TMCC1 VPS13B	1.82e-05	1496	186	22	32877691
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ACACB TMEM94 ESYT1 LRCH1 SLC3A2 CELSR2 ARHGEF10 EEPD1 NHS MACF1 UTRN	1.85e-05	421	186	11	36976175
Pubmed	Functional proteomics mapping of a human signaling pathway.	A2M DMTF1 COL4A2 HIVEP1 PSAP ZNF329 MRTFB UBXN11 POLI MACF1 HERC2 UTRN RUBCN	1.98e-05	591	186	13	15231748
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	USP36 RELCH SDK2 ZBTB4 PHRF1 PLCE1	2.01e-05	103	186	6	10819331
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DMTF1 KLF12 STARD8 PSAP COLGALT1 SRCAP ATF2 KIFC2 MEN1 AOPEP ZNF638 OTUD4 MACF1 MTO1 CPLANE1 TASOR UTRN VPS13B	2.32e-05	1084	186	18	11544199
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HSPD1 USP36 HIVEP1 NOP53 ESYT1 AZGP1 ZNF329 THUMPD3 RPSA COLGALT1 CMYA5 OGDH WDR43 SLC3A2 LRRC47 IPO9 NUP210 DOCK7 GALNT5 BSN IQGAP3	2.77e-05	1425	186	21	30948266
Pubmed	Mice Deficient in Nucleoporin Nup210 Develop Peripheral T Cell Alterations.	NUP210 FOXP3	2.84e-05	2	186	2	30323813
Pubmed	Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer.	PALB2 BRCA1	2.84e-05	2	186	2	34245638
Pubmed	Characterization of the human homolog of the IL-4 induced gene-1 (Fig1).	TBC1D17 IL4I1	2.84e-05	2	186	2	12031486
Pubmed	Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway.	PALB2 BRCA1	2.84e-05	2	186	2	35006619
Pubmed	The living eye "disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition.	RBP3 FOXP3	2.84e-05	2	186	2	22238462
Pubmed	Molecular chaperone, HSP60, and cytochrome P450 2E1 co-expression in dilated cardiomyopathy.	HSPD1 CYP2E1	2.84e-05	2	186	2	15763499
Pubmed	The immunosuppressive enzyme IL4I1 promotes FoxP3(+) regulatory T lymphocyte differentiation.	IL4I1 FOXP3	2.84e-05	2	186	2	25778793
Pubmed	Slc3a2 Mediates Branched-Chain Amino-Acid-Dependent Maintenance of Regulatory T Cells.	SLC3A2 FOXP3	2.84e-05	2	186	2	29141216
Pubmed	Evidence of Intertissue Differences in the DNA Damage Response and the Pro-oncogenic Role of NF-κB in Mice with Disengaged BRCA1-PALB2 Interaction.	PALB2 BRCA1	2.84e-05	2	186	2	29739757
Pubmed	Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.	MEN1 BRCA1	2.84e-05	2	186	2	19837273
Pubmed	Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation.	PALB2 BRCA1	2.84e-05	2	186	2	24591564
Pubmed	Regulation of cell proliferation and apoptosis through fibrocystin-prosaposin interaction.	PSAP PKHD1	2.84e-05	2	186	2	20709014
Pubmed	Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation by glycogen synthase kinase-3 beta.	GSK3B CRY2	2.84e-05	2	186	2	15980066
Pubmed	Antiparallel Coiled-Coil Interactions Mediate the Homodimerization of the DNA Damage-Repair Protein PALB2.	PALB2 BRCA1	2.84e-05	2	186	2	30289697
Pubmed	Critical link between glycogen synthase kinase 3β and forkhead box P3 in patients with chronic rhinosinusitis with nasal polyps.	GSK3B FOXP3	2.84e-05	2	186	2	26431581
Pubmed	Trophoblast VIP deficiency entails immune homeostasis loss and adverse pregnancy outcome in mice.	VIP FOXP3	2.84e-05	2	186	2	30204500
Pubmed	Connexin 43 signaling enhances the generation of Foxp3+ regulatory T cells.	GJA1 FOXP3	2.84e-05	2	186	2	21642545
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	PSAP PIGS COLGALT1 SLC3A2 ITFG1 PXDN NUP210	3.07e-05	164	186	7	32409323
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	EPHB6 COL4A2 PRTG MGAT4B RBM33 TMEM94 PKD1L1 SLC3A2 PXDN ARHGEF10 RAPGEF3 SUN2 EPC1 TONSL VPS13A MRNIP HERC2 UTRN RUBCN	3.09e-05	1215	186	19	15146197
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	TANC2 SPEG RPSA GSK3B PRRT3 MACF1 BSN PRRC2A	3.71e-05	231	186	8	16452087
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HSPD1 USP36 ESYT1 AZGP1 BAG3 THUMPD3 RPSA COLGALT1 SRCAP GTF3C4 GSK3B SLC3A2 LRRC47 IPO9 PPM1F TPP1 ZNF638 MACF1 HERC2 UTRN	4.17e-05	1353	186	20	29467282
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	HSPD1 USP36 ACACB ESYT1 BAG3 RPSA SRCAP GTF3C4 WDR43 SLC3A2 MRTFB ZNF638 MACF1 TASOR UTRN PRRC2A	4.65e-05	934	186	16	33916271
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	AZGP1 DACT2 MUC16 ZNF362 ARFGEF3 NKD2 EPC1 VPS13A IGSF9B HERC2 CPLANE1 UTRN	4.65e-05	552	186	12	10737800
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	A2M ZNF362 SRCAP PALB2 MEN1 LRRC47 IPO9 BRCA1 EPC1 TONSL DOCK7 ZNF638 UTRN	4.87e-05	645	186	13	25281560
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	A2M MGAT4B OBSL1 COLGALT1 TBC1D17 TPP1 TONSL DOCK7 ZNF638 TASOR IQGAP3 RUBCN PLCE1	5.26e-05	650	186	13	38777146
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	A2M TANC2 TMEM94 TUBGCP5 LRRC47 LPA NAV3 OTUD4 IGSF9B HERC2 PRRC2A	5.52e-05	475	186	11	31040226
Pubmed	Large-scale concatenation cDNA sequencing.	DMTF1 TMEM94 LPCAT4 OBSL1 ATF2 KIFC2 SLC3A2 UBXN11 IPO9 RAPGEF3 SUN2 VPS13A	6.11e-05	568	186	12	9110174
Pubmed	Discovery of a Human Testis-specific Protein Complex TEX101-DPEP3 and Selection of Its Disrupting Antibodies.	HSPD1 PSAP PKD1L1 APCS CUL9 GGT5 TPP1 DPEP3	6.30e-05	249	186	8	30097533
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MPP1 HIVEP1 RBM33 OBSL1 CUL9 SRCAP GSK3B ARFGEF3 MRTFB TONSL MACF1 BSN	8.48e-05	588	186	12	38580884
Pubmed	VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites.	ESYT1 VPS13A	8.50e-05	3	186	2	30093493
Pubmed	GSK3β modulates NF-κB activation and RelB degradation through site-specific phosphorylation of BCL10.	RELB GSK3B	8.50e-05	3	186	2	29358699
Pubmed	A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago.	PALB2 BRCA1	8.50e-05	3	186	2	27469594
Pubmed	Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors.	PALB2 BRCA1	8.50e-05	3	186	2	32029870
Pubmed	BRCA1 and RNAi factors promote repair mediated by small RNAs and PALB2-RAD52.	PALB2 BRCA1	8.50e-05	3	186	2	33536619
Pubmed	BAG3 epigenetically regulates GALNT10 expression via WDR5 and facilitates the stem cell-like properties of platin-resistant ovarian cancer cells.	GALNT10 BAG3	8.50e-05	3	186	2	34111434
Pubmed	MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer.	BRCA1 FOXP3	8.50e-05	3	186	2	28562349
Pubmed	Coupling of Homologous Recombination and the Checkpoint by ATR.	PALB2 BRCA1	8.50e-05	3	186	2	28089683
Pubmed	Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.	PALB2 BRCA1	8.50e-05	3	186	2	18501021
Pubmed	The Epac-Phospholipase Cε Pathway Regulates Endocannabinoid Signaling and Cocaine-Induced Disinhibition of Ventral Tegmental Area Dopamine Neurons.	RAPGEF3 PLCE1	8.50e-05	3	186	2	28209735
Pubmed	The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth.	FRMD8 FRMD8P1	8.50e-05	3	186	2	36720499
Pubmed	BRCA and pancreatic cancer.	PALB2 BRCA1	8.50e-05	3	186	2	23846919
Pubmed	Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.	LATS2 FOXP3	8.50e-05	3	186	2	21278236
Pubmed	Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.	PALB2 BRCA1	8.50e-05	3	186	2	34036661
Pubmed	Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients.	PALB2 BRCA1	8.50e-05	3	186	2	27328445
Pubmed	Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance.	SIGLEC1 FOXP3	8.50e-05	3	186	2	30413362
Pubmed	Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.	PALB2 BRCA1	8.50e-05	3	186	2	26219241
Pubmed	BRCA and PALB2 mutations in a cohort of male breast cancer with one bilateral case.	PALB2 BRCA1	8.50e-05	3	186	2	32058061
Pubmed	DYRK1A and glycogen synthase kinase 3beta, a dual-kinase mechanism directing proteasomal degradation of CRY2 for circadian timekeeping.	GSK3B CRY2	8.50e-05	3	186	2	20123978
Pubmed	Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma.	PALB2 BRCA1	8.50e-05	3	186	2	29802286
Pubmed	PALB2 links BRCA1 and BRCA2 in the DNA-damage response.	PALB2 BRCA1	8.50e-05	3	186	2	19268590
Pubmed	Skin stem cells orchestrate directional migration by regulating microtubule-ACF7 connections through GSK3β.	GSK3B MACF1	8.50e-05	3	186	2	21295697
Pubmed	Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.	PALB2 BRCA1	8.50e-05	3	186	2	24285729
Pubmed	Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm.	CRY2 GJA1	8.50e-05	3	186	2	22549838
Pubmed	GSK-3beta regulates proper mitotic spindle formation in cooperation with a component of the gamma-tubulin ring complex, GCP5.	TUBGCP5 GSK3B	8.50e-05	3	186	2	18316369
Pubmed	Epac1 and Epac2 are differentially involved in inflammatory and remodeling processes induced by cigarette smoke.	RAPGEF3 PLCE1	8.50e-05	3	186	2	25103224
Pubmed	The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.	BRCA1 EEPD1	8.50e-05	3	186	2	29145865
Pubmed	PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response.	PALB2 BRCA1	8.50e-05	3	186	2	30337689
Pubmed	TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.	BRCA1 HERC2	8.50e-05	3	186	2	25480944
Pubmed	Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.	PALB2 BRCA1	8.50e-05	3	186	2	28024868
Pubmed	CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression.	SLC3A2 PPM1F	8.50e-05	3	186	2	30470261
Pubmed	Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.	PALB2 BRCA1	8.50e-05	3	186	2	23935836
Pubmed	Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer.	PALB2 BRCA1	8.50e-05	3	186	2	25833210
Pubmed	Role of the NF-κB Family Member RelB in Regulation of Foxp3+ Regulatory T Cells In Vivo.	RELB FOXP3	8.50e-05	3	186	2	29298831
Pubmed	The risk of breast cancer due to PALB2 gene mutations.	PALB2 BRCA1	8.50e-05	3	186	2	28791855
Pubmed	A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer.	PALB2 BRCA1	8.50e-05	3	186	2	32669374
Pubmed	Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1.	GSK3B BRCA1	8.50e-05	3	186	2	17428466
Pubmed	FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth.	FRMD8 FRMD8P1	8.50e-05	3	186	2	37527040
Pubmed	Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program.	PALB2 BRCA1	8.50e-05	3	186	2	35363308
Pubmed	Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.	RAPGEF3 PLCE1	8.50e-05	3	186	2	18957419
Pubmed	Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy.	PALB2 BRCA1	8.50e-05	3	186	2	21989927
Pubmed	Progesterone receptor A stability is mediated by glycogen synthase kinase-3β in the Brca1-deficient mammary gland.	GSK3B BRCA1	8.50e-05	3	186	2	23880761
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PRTG SDK2 DSCAM SPEG LRFN3 OBSL1 KIRREL2 PXDN HMCN2 CD101 IGSF9B SIGLEC1	6.22e-10	161	118	12	593
GeneFamily	Fibronectin type III domain containing	EPHB6 PRTG SDK2 DSCAM LRFN3 FNDC5 CMYA5 IGSF9B	1.01e-05	160	118	8	555
GeneFamily	Immunoglobulin like domain containing	SDK2 DSCAM OBSL1 KIRREL2 HMCN2 CD101 FCRLB IGSF9B	3.92e-05	193	118	8	594
GeneFamily	EF-hand domain containing\|Plakins	EPPK1 MACF1	1.15e-03	8	118	2	939
Coexpression	GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	TANC2 KLF12 PEX10 GSK3B ITFG1 MRTFB OTUD4 HERC2 UTRN VPS13B	1.55e-06	197	186	10	M7403
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	DMTF1 LPCAT4 ATF2 VPS13A NAV3 ZNF638 AUTS2 OTUD4 MTCL1 TMCC1 VPS13B	1.07e-05	300	186	11	M8702
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	A2M COL4A2 COBLL1 GGT5 GJA1 MRTFB NKD2 HECW2	1.91e-06	198	186	8	72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	A2M DMTF1 KLF12 RELCH VPS13A MACF1 UTRN VPS13B	1.98e-06	199	186	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Severe_COVID-19-Myeloid-MoAM4\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	A2M MPP1 PSAP COLGALT1 TPP1 EEPD1 ZNF638 SIGLEC1	2.06e-06	200	186	8	30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M MPP1 PSAP COLGALT1 TPP1 EEPD1 ZNF638 SIGLEC1	2.06e-06	200	186	8	4f481d87e30195365900acb5d50641a9e7b2f462
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M MPP1 PSAP COLGALT1 TPP1 EEPD1 ZNF638 SIGLEC1	2.06e-06	200	186	8	cf720d3973e79ffd4c6e763a7284799ced22a274
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	A2M MPP1 PSAP COLGALT1 TPP1 EEPD1 ZNF638 SIGLEC1	2.06e-06	200	186	8	5490393c5f54748f912676e19b58bd1320415a06
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M MPP1 PSAP COLGALT1 TPP1 EEPD1 ZNF638 SIGLEC1	2.06e-06	200	186	8	df821ac12953e44fcfedbbefb35a4976e406ccd6
ToppCell	facs-Skin-nan-24m-Epithelial-inner_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M ZYG11A NWD1 RPSA KIRREL2 HOGA1 PKHD1	4.09e-06	155	186	7	fa2776d258e0420b2895de1008e292ad7725dac0
ToppCell	ASK428-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	KLF12 COBLL1 MUC16 GGT5 ARHGEF10 GALNT5 PDZD2	9.07e-06	175	186	7	e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 COBLL1 DACT2 OBSL1 ARFGEF3 AUTS2 GALNT5	1.05e-05	179	186	7	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PKHD1L1 GGT5 GJA1 HECW2 NAV3 MACF1 UTRN	1.13e-05	181	186	7	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	A2M GALNT10 NOP53 FHAD1 MACF1 MS4A8 RUBCN	1.26e-05	184	186	7	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PKHD1L1 GGT5 GJA1 HECW2 NAV3 MACF1 UTRN	1.35e-05	186	186	7	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 KIFC2 ARSD PKHD1 KIFC3 GALNT5 UTRN	1.40e-05	187	186	7	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL4A2 KLF12 CD248 GGT5 ATXN1 AUTS2	1.65e-05	192	186	7	4022f208eb5db760abd0aac782a25e8ab63efc64
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ATXN1 AOPEP PKHD1 NHS MACF1 VPS13B PDZD2	1.65e-05	192	186	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	GTF3C4 GSK3B ARFGEF3 PTAR1 CPLANE1 UTRN VPS13B	1.71e-05	193	186	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	A2M RELCH TUBGCP5 VPS13A MACF1 UTRN VPS13B	1.71e-05	193	186	7	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M SDK2 MAOB AZGP1 NKD2 MACF1 GPSM1	1.71e-05	193	186	7	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M PSAP SIGLEC15 ARFGEF3 EEPD1 SIGLEC1 IL4I1	1.89e-05	196	186	7	bd2c2de103e28b65ea537c22f71225cb0deef1e0
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL4A2 CD248 COBLL1 GGT5 PXDN HECW2 PLCE1	1.89e-05	196	186	7	12d9028f90c057c6e5cff00301793fa550e86c5a
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 ATXN1 AOPEP AUTS2 TMCC1 VPS13B PDZD2	1.89e-05	196	186	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Bronchial-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EPHB6 MAOB MUC16 PKHD1L1 PRRT3 IGSF9B KCNH5	1.89e-05	196	186	7	96e5c6d155273e82ebafa180df8bb589c3e3e54e
ToppCell	Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EPHB6 MAOB MUC16 PKHD1L1 PRRT3 IGSF9B KCNH5	1.89e-05	196	186	7	ce13af36fc2932e8125013041742593ff3d07e86
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M PSAP SIGLEC15 ARFGEF3 EEPD1 SIGLEC1 IL4I1	1.89e-05	196	186	7	072a4150ae521c6589b0f7cd60e975fb33715bf4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	A2M COL4A2 GGT5 GJA1 PXDN PPM1F HECW2	1.95e-05	197	186	7	9244f087ba4b60fdc81d54ce91860de715b3e12c
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PLB1 LRCH1 AOPEP PKHD1 KIFC3 GALNT5 UTRN	1.95e-05	197	186	7	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M TANC2 SDK2 MAOB NKD2 MACF1 VPS13B	1.95e-05	197	186	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 ATXN1 AOPEP AUTS2 TMCC1 VPS13B PDZD2	2.02e-05	198	186	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	A2M COL4A2 COBLL1 GGT5 GJA1 NKD2 HECW2	2.08e-05	199	186	7	9c40b3ee39860e9d8edafd007daec11abdd95435
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	A2M COL4A2 COBLL1 GGT5 GJA1 NKD2 HECW2	2.08e-05	199	186	7	72b34bce8157abe389e95cd3ed8ba578dce0cbf6
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_4\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	COL4A2 STARD8 TMEM94 EPC1 CPLANE1 GPSM1	2.13e-05	134	186	6	9e12aac8f42790c2f104dfd61c87aa99fc7925f1
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	A2M SDK2 MAOB NKD2 NAV3 MACF1 GPSM1	2.15e-05	200	186	7	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M SDK2 MAOB NKD2 NAV3 MACF1 GPSM1	2.15e-05	200	186	7	a510deaada669e690329183e18df02870bd204b3
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	PRTG GALNT10 NWD1 COBLL1 GJA1 FHAD1 GALNT5	2.15e-05	200	186	7	5fb90118d3abc28d72bc483e68317255090a04c7
ToppCell	Severe-Myeloid-Macrophages-FCN1-SPP1+\|Severe / Condition, Lineage, Cell class and cell subclass	A2M MPP1 PSAP COLGALT1 TPP1 ZNF638 SIGLEC1	2.15e-05	200	186	7	b8cd209b810312793465b28bb2a6cbe5d94da91f
ToppCell	COVID-19-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	A2M MGAT4B PSAP TPP1 EEPD1 MACF1 HERC2	2.15e-05	200	186	7	a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M SDK2 MAOB NKD2 NAV3 MACF1 GPSM1	2.15e-05	200	186	7	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	COL4A2 CD248 WARS2 EEPD1 NHS MRNIP	2.96e-05	142	186	6	85e573616e54d41391b4ad8c3d38e4ca92112673
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DSCAM GJA1 PXDN MS4A8 IL4I1 IQGAP3	3.08e-05	143	186	6	27e06327f96cb72bd111ea6ece6307e5ebb3a146
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DSCAM GJA1 PXDN MS4A8 IL4I1 IQGAP3	3.08e-05	143	186	6	4edef95ae2a1ef4fc4b0d4fadf75bfc54b583932
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PM20D1 CUL9 TPP1 NHS IQGAP3 FOXP3	4.33e-05	152	186	6	6d02b50e9e9ecf820f84a79e46d153a4840a1cfe
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	COL4A2 EPPK1 HMCN2 NHS UTRN PLCE1	5.96e-05	161	186	6	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRS3 PALB2 BRCA1 CELSR2 TONSL GPSM1	7.30e-05	167	186	6	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TEP1 ANKRD55 KIFC2 TMEM132E SIGLEC1 RUBCN	7.30e-05	167	186	6	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MPP1 HIVEP1 RELB TPP1 SIGLEC1 IL4I1	8.06e-05	170	186	6	9ac1ef57f14418a5dd2aa16861c3df698c28f5ed
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 CMYA5 RAPGEF3 PKHD1 KIFC3 CDH16	8.06e-05	170	186	6	928e42c51a7079c506f21c669c4e4c1a0df84d77
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL4A2 DCHS2 CD248 COBLL1 GGT5 NHS	8.32e-05	171	186	6	a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic-Progen\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EPHB6 DCHS2 NOP53 KIRREL2 PXDN ARHGEF10	8.32e-05	171	186	6	09b3fa120f63c411f8a0dd6bd230a9720ce83fb1
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic-Progen-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EPHB6 DCHS2 NOP53 KIRREL2 PXDN ARHGEF10	8.32e-05	171	186	6	61d622153b91702ef21b0efc7b9581e592b7ccea
ToppCell	facs-Liver-Non-hepatocytes-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPD1 BAAT ADH4 HOGA1 ALAS1 PRPH	8.59e-05	172	186	6	feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2
ToppCell	facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPD1 BAAT ADH4 HOGA1 ALAS1 PRPH	8.59e-05	172	186	6	8aed9c113f27d00401c272a3684495a4bc75bd0f
ToppCell	facs-Liver-Non-hepatocytes-3m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPD1 BAAT ADH4 HOGA1 ALAS1 PRPH	8.59e-05	172	186	6	9adfb4a65669cc536343616637058d0a4728013f
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRTG EPPK1 GJA1 CSN3 IQGAP3 PLCE1	9.16e-05	174	186	6	a0ccda8fd6f55251cdeff24cf66e72e4a31d2104
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M COL4A2 PRTG GGT5 PXDN NKD2	9.16e-05	174	186	6	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DSCAM ANKRD55 HMCN2 PPM1F HECW2 CD101	9.75e-05	176	186	6	64e426f5e84884ce2c29acf6f4b958962a63927f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1L1 GJA1 HECW2 NAV3 GPSM1 PLCE1	1.01e-04	177	186	6	c8a51e480b978dc0ded85583261f2c892e085be8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1L1 GJA1 HECW2 NAV3 GPSM1 PLCE1	1.01e-04	177	186	6	c274fbdc141855ff4581d437d4997c64cc193278
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1L1 GJA1 HECW2 NAV3 GPSM1 PLCE1	1.01e-04	177	186	6	f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PKHD1L1 GGT5 GJA1 NAV3 MACF1 UTRN	1.04e-04	178	186	6	ad3de3e03a401dac64431a541899445262246347
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VIP PRTG ANKRD55 HMCN2 NKD2 PLCE1	1.04e-04	178	186	6	3c973aac16988e88f5677d3d695dd772ccfd6570
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL4A2 GGT5 PXDN NKD2 EEPD1	1.04e-04	178	186	6	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	Somatosensory_Cortex_(S1)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EPHB6 KLF12 PSAP ATXN1 AUTS2 MTCL1	1.07e-04	179	186	6	82348bf56a4525b2f485696cab5b2ea6e96c2f91
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	TDRKH ESYT1 MUC16 CUL9 ANKRD55 GGT5	1.07e-04	179	186	6	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A2 SDK2 GJA1 PXDN NKD2 PDZD2	1.07e-04	179	186	6	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG COBLL1 IGSF9B UTRN PLCE1 PRPH	1.10e-04	180	186	6	a37cc885fe3f6cb9df69d43358064c83c18412e7
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG COBLL1 IGSF9B UTRN PLCE1 PRPH	1.10e-04	180	186	6	63a6d532b16b8b15c7c9102148d7297ee3afd641
ToppCell	IPF-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	SDK2 HIVEP1 COBLL1 PXDN AUTS2 RUBCN	1.10e-04	180	186	6	0f8567aa835d4e3a52f6631ae15216eca18a030c
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	A2M MPP1 STARD8 DSCAM OBSL1 SIGLEC1	1.10e-04	180	186	6	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M COL4A2 GGT5 PXDN HMCN2 NKD2	1.10e-04	180	186	6	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 RAPGEF3 NAV3 AUTS2 IGSF9B PLCE1	1.14e-04	181	186	6	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 RAPGEF3 NAV3 AUTS2 IGSF9B PLCE1	1.14e-04	181	186	6	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M STARD8 RELB PPM1F HECW2 UTRN	1.17e-04	182	186	6	63b41b538b26bc899558807fd035e543611f8c52
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A2 ANKRD55 HMCN2 VWA5A NHS PLCE1	1.17e-04	182	186	6	08aff7112c9dac0ef5540300516a604782b21169
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PSAP ACACB SIRPB1 COLGALT1 TPP1 SIGLEC1	1.21e-04	183	186	6	103c4c4595d8daa677679fd2fa1e99cd398e56dd
ToppCell	droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 PLB1 MAOB CYP2E1 GJA1 IGSF9B	1.21e-04	183	186	6	19e7be1cfdd111bfb840532a6f7c780345dffccf
ToppCell	droplet-Lung-nan-21m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 PLB1 MAOB CYP2E1 GJA1 IGSF9B	1.21e-04	183	186	6	b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M PKHD1L1 ARFGEF3 PKHD1 NAV3 PLCE1	1.24e-04	184	186	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	CYP2E1 PCDH20 ARFGEF3 VWA5A IL4I1 PDZD2	1.24e-04	184	186	6	479e60f76c191253e23699c9dd7ef7efc08c59ad
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M PKHD1L1 ARFGEF3 PKHD1 NAV3 PLCE1	1.24e-04	184	186	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	DCHS2 TDRKH MGAT4B PSAP PALB2 VWA5A	1.24e-04	184	186	6	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M PKHD1L1 ARFGEF3 PKHD1 NAV3 PLCE1	1.24e-04	184	186	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	TANC2 NOP53 DCLRE1B ARSD VPS13A UTRN	1.24e-04	184	186	6	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	droplet-Lung-nan-21m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 MGAT4B ARHGAP39 COLGALT1 RAB44 MS4A8	1.32e-04	186	186	6	8f77e552e613b6e124443c7f6ef5c1316a5ff8db
ToppCell	normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac\|Myeloid_cells / Location, Cell class and cell subclass	STARD8 AOPEP HCFC2 GPSM1 TASOR FAM8A1	1.32e-04	186	186	6	701eea0016d69f0f9d29b613948f91239096e6c7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZYG11A TMEM132E PKHD1 NHS KIFC3 PDZD2	1.32e-04	186	186	6	5784d255e9ca449d375d81938d0fbbd8a7eb44f6
ToppCell	droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 MGAT4B ARHGAP39 COLGALT1 RAB44 MS4A8	1.32e-04	186	186	6	f1aa0c58336d23bcbe52a59e7af954d20085bdb6
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 PKHD1 MTCL1 KIFC3 GALNT5 UTRN	1.32e-04	186	186	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 DACT2 ARFGEF3 AUTS2 MTCL1 GALNT5	1.32e-04	186	186	6	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	A2M KLF12 COBLL1 HMCN2 NHS MACF1	1.40e-04	188	186	6	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	STARD8 RAB44 HMCN2 NKD2 PRR33 RAPGEF3	1.40e-04	188	186	6	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 APCS GJA1 PKHD1 KIFC3 PLCE1	1.40e-04	188	186	6	842982de2197770f999a70083ed9fca40ac22d79
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 APCS GJA1 PKHD1 KIFC3 PLCE1	1.40e-04	188	186	6	a0815eaf68eedd6e5ec4af520df80a6ab4eb0864
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	TANC2 PRTG EPPK1 COBLL1 ARFGEF3 AUTS2	1.40e-04	188	186	6	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	control-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	STARD8 FRS3 SIRPB1 UBXN11 ARSD IGSF9B	1.44e-04	189	186	6	bdfd120900ba58d5e54765f7b576e1f8cc2401bf
ToppCell	IPF-Epithelial-Aberrant_Basaloid\|Epithelial / Disease state, Lineage and Cell class	COL4A2 GALNT10 BAAT GJA1 PXDN GALNT5	1.44e-04	189	186	6	4178be3292ff4a8a1d8098f638d4b8d15164d2c6
ToppCell	facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 RAPGEF3 PPM1F EEPD1 NAV3 UTRN	1.44e-04	189	186	6	30dc1725d43a60017fb12d706f1f85a33de4947e
ToppCell	facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 RAPGEF3 PPM1F EEPD1 NAV3 UTRN	1.44e-04	189	186	6	1be5067c1e45af7d09c1fd6955952cb9e031a3a0
ToppCell	Striatum-Endothelial\|Striatum / BrainAtlas - Mouse McCarroll V32	COL4A2 CD248 ESYT1 COBLL1 GGT5 NKD2	1.44e-04	189	186	6	95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d
ToppCell	wk_20-22-Hematologic-Myeloid-APOE+_Mac2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MPP1 DSCAM SIGLEC15 TPP1 SIGLEC1 IL4I1	1.44e-04	189	186	6	e189ef6066f87177d758f0e3ed9a17e01031a391
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	COBLL1 RELB OGDH CELSR2 LPA DOCK7 MACF1	3.15e-05	144	181	7	EFO_0004611, EFO_0020943
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	COBLL1 OBSL1 PEX10 RELB GSK3B ADH4 CELSR2 LPA EEPD1 DOCK7	3.16e-05	321	181	10	EFO_0004612, EFO_0004639
Disease	lipid measurement, high density lipoprotein cholesterol measurement	COBLL1 OBSL1 PEX10 RELB GSK3B ADH4 CELSR2 LPA EEPD1 DOCK7	4.00e-05	330	181	10	EFO_0004529, EFO_0004612
Disease	optic disc size measurement	TANC2 KLF12 LRCH1 ARHGEF10 NAV3 MACF1 PLCE1 PDZD2	4.14e-05	205	181	8	EFO_0004832
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ACACB COBLL1 RELB CELSR2 LPA EEPD1 DOCK7 MACF1 TASOR	8.35e-05	291	181	9	EFO_0008317, EFO_0020946
Disease	free cholesterol to total lipids in large LDL percentage	COBLL1 CELSR2 LPA DOCK7 MACF1	9.40e-05	74	181	5	EFO_0022280
Disease	sleep duration, high density lipoprotein cholesterol measurement	TMEM94 COBLL1 RELB CELSR2 DPEP3 MACF1	1.05e-04	121	181	6	EFO_0004612, EFO_0005271
Disease	Cohen syndrome (implicated_via_orthology)	VPS13A VPS13B	1.12e-04	3	181	2	DOID:0111590 (implicated_via_orthology)
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	ACACB COBLL1 CELSR2 LPA DOCK7	1.91e-04	86	181	5	EFO_0008595, EFO_0020945
Disease	facial height measurement	USP36 GSK3B ATXN1 CSN3 TMEM132E LPA	2.52e-04	142	181	6	EFO_0007856
Disease	cholesteryl esters to total lipids in IDL percentage	COBLL1 RELB LPA MACF1	2.53e-04	50	181	4	EFO_0022247
Disease	cholesterol to total lipids in small HDL percentage	COBLL1 CELSR2 LPA DOCK7	2.73e-04	51	181	4	EFO_0022240
Disease	free cholesterol to total lipids in small LDL percentage	COBLL1 CELSR2 LPA DOCK7	3.17e-04	53	181	4	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	COBLL1 CELSR2 LPA DOCK7	3.17e-04	53	181	4	EFO_0022258
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	COBLL1 RELB CELSR2 LPA DOCK7 MACF1	3.38e-04	150	181	6	EFO_0004611, EFO_0020947
Disease	total lipids in medium VLDL	COBLL1 CELSR2 LPA DOCK7	3.41e-04	54	181	4	EFO_0022153
Disease	triglycerides in medium HDL measurement	COBLL1 CELSR2 LPA DOCK7	3.41e-04	54	181	4	EFO_0022321
Disease	cholesterol to total lipids in very large VLDL percentage	COBLL1 CELSR2 LPA DOCK7	3.41e-04	54	181	4	EFO_0022244
Disease	triglycerides in medium VLDL measurement	COBLL1 CELSR2 LPA DOCK7	3.66e-04	55	181	4	EFO_0022155
Disease	Antithrombotic agent use measurement	COL4A2 CELSR2 AOPEP LPA	3.66e-04	55	181	4	EFO_0009925
Disease	cholesterol to total lipids in large HDL percentage	COBLL1 CELSR2 LPA DOCK7	3.66e-04	55	181	4	EFO_0022234
Disease	hepatocellular adenoma (biomarker_via_orthology)	A2M CYP2E1	3.70e-04	5	181	2	DOID:0050868 (biomarker_via_orthology)
Disease	hereditary breast ovarian cancer syndrome (is_implicated_in)	PALB2 BRCA1	3.70e-04	5	181	2	DOID:5683 (is_implicated_in)
Disease	triglycerides in LDL measurement	COBLL1 CELSR2 LPA DOCK7	3.92e-04	56	181	4	EFO_0022320
Disease	stomach carcinoma (is_marker_for)	AZGP1 SLC3A2 BRCA1	4.18e-04	24	181	3	DOID:5517 (is_marker_for)
Disease	free cholesterol to total lipids in medium VLDL percentage	COBLL1 CELSR2 LPA DOCK7	4.20e-04	57	181	4	EFO_0022284
Disease	triglycerides to total lipids in small LDL percentage	COBLL1 CELSR2 LPA DOCK7	4.79e-04	59	181	4	EFO_0022337
Disease	phospholipids in VLDL measurement	COBLL1 CELSR2 LPA DOCK7	4.79e-04	59	181	4	EFO_0022301
Disease	cholesteryl esters to total lipids in large HDL percentage	COBLL1 CELSR2 LPA DOCK7	4.79e-04	59	181	4	EFO_0022248
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	ACACB COBLL1 RELB CELSR2 LPA DOCK7 JAZF1	5.00e-04	225	181	7	EFO_0008317, EFO_0010351
Disease	familial hyperlipidemia	COBLL1 RELB CELSR2 LPA DOCK7	5.05e-04	106	181	5	MONDO_0001336
Disease	alcohol consumption measurement, high density lipoprotein cholesterol measurement	COBLL1 CELSR2 LPA DPEP3 DOCK7 CDH16	5.09e-04	162	181	6	EFO_0004612, EFO_0007878
Disease	total lipids in VLDL measurement	COBLL1 CELSR2 LPA DOCK7	5.11e-04	60	181	4	EFO_0022314
Disease	cortical thickness	A2M COL4A2 PRTG PM20D1 CUL9 RPSA LRCH1 RAB44 WARS2 DOCK7 PKHD1 NAV3 AUTS2 MACF1 MTCL1 PLCE1 PDZD2	5.26e-04	1113	181	17	EFO_0004840
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	COBLL1 RELB CELSR2 LPA ALAS1	5.27e-04	107	181	5	EFO_0004614, EFO_0004615
Disease	free cholesterol in VLDL measurement	COBLL1 CELSR2 LPA DOCK7	5.44e-04	61	181	4	EFO_0022276
Disease	triglycerides in medium LDL measurement	COBLL1 CELSR2 LPA DOCK7	5.79e-04	62	181	4	EFO_0022322
Disease	free cholesterol in very large HDL measurement	COBLL1 CELSR2 LPA DOCK7	5.79e-04	62	181	4	EFO_0022273
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	COBLL1 BAG3 RELB ADH4 CELSR2 LPA DOCK7 JAZF1	5.95e-04	303	181	8	EFO_0004612, EFO_0020945
Disease	triglycerides to total lipids in IDL percentage	COBLL1 CELSR2 LPA DOCK7	6.15e-04	63	181	4	EFO_0022329
Disease	triglycerides to total lipids in medium VLDL percentage	COBLL1 CELSR2 LPA DOCK7	6.15e-04	63	181	4	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	COBLL1 CELSR2 LPA DOCK7	6.15e-04	63	181	4	EFO_0022239
Disease	alcohol drinking, high density lipoprotein cholesterol measurement	COBLL1 CELSR2 LPA DPEP3 DOCK7 CDH16	6.16e-04	168	181	6	EFO_0004329, EFO_0004612
Disease	cholesteryl esters to total lipids in medium VLDL percentage	COBLL1 CELSR2 LPA DOCK7	6.53e-04	64	181	4	EFO_0022253
Disease	susceptibility to childhood ear infection measurement	HECW2 NUP210 AUTS2 GALNT5 BSN VPS13B	6.76e-04	171	181	6	EFO_0007904
Disease	triglycerides in small LDL measurement	COBLL1 CELSR2 LPA DOCK7	6.93e-04	65	181	4	EFO_0022323
Disease	cholesterol in large VLDL measurement	COBLL1 CELSR2 LPA DOCK7	6.93e-04	65	181	4	EFO_0021902
Disease	cholesterol in very large VLDL measurement	COBLL1 CELSR2 LPA DOCK7	6.93e-04	65	181	4	EFO_0022230
Disease	Carcinoma, Granular Cell	HSPD1 MPP1 CYP2E1 AZGP1 PLCE1	7.61e-04	116	181	5	C0205644
Disease	Adenocarcinoma, Tubular	HSPD1 MPP1 CYP2E1 AZGP1 PLCE1	7.61e-04	116	181	5	C0205645
Disease	Adenocarcinoma, Oxyphilic	HSPD1 MPP1 CYP2E1 AZGP1 PLCE1	7.61e-04	116	181	5	C0205642
Disease	Carcinoma, Cribriform	HSPD1 MPP1 CYP2E1 AZGP1 PLCE1	7.61e-04	116	181	5	C0205643
Disease	Adenocarcinoma, Basal Cell	HSPD1 MPP1 CYP2E1 AZGP1 PLCE1	7.61e-04	116	181	5	C0205641
Disease	Adenocarcinoma	HSPD1 MPP1 CYP2E1 AZGP1 PLCE1	7.61e-04	116	181	5	C0001418
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	COBLL1 OBSL1 GSK3B ADH4 CELSR2 LPA EEPD1 DOCK7	7.66e-04	315	181	8	EFO_0004612, EFO_0008591
Disease	total lipids in large VLDL	COBLL1 CELSR2 LPA DOCK7	7.77e-04	67	181	4	EFO_0022175
Disease	cholesterol to total lipids in very small VLDL percentage	COBLL1 CELSR2 LPA DOCK7	7.77e-04	67	181	4	EFO_0022245
Disease	free cholesterol in large VLDL measurement	COBLL1 CELSR2 LPA DOCK7	8.21e-04	68	181	4	EFO_0022265
Disease	triglycerides to total lipids in very small VLDL percentage	COBLL1 CELSR2 LPA DOCK7	8.68e-04	69	181	4	EFO_0022341
Disease	sugar consumption measurement	COL4A2 ATF2 PKHD1 IGSF9B VPS13B	8.86e-04	120	181	5	EFO_0010158
Disease	cholesteryl esters to total lipids in large LDL percentage	CELSR2 LPA DOCK7	8.99e-04	31	181	3	EFO_0022249
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	COBLL1 RELB CELSR2 LPA MACF1	9.20e-04	121	181	5	EFO_0008595, EFO_0020943
Disease	Malignant neoplasm of breast	STARD8 PIGS APCS ATF2 PCDH20 PALB2 GJA1 BRCA1 PPM1F NHS MACF1 GALNT5 HERC2 PRRC2A VPS13B FOXP3	9.98e-04	1074	181	16	C0006142
Disease	heart failure	USP36 BAG3 CELSR2 AOPEP LPA ZNF638	1.02e-03	185	181	6	EFO_0003144
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	COBLL1 RELB CELSR2 LPA DOCK7	1.10e-03	126	181	5	EFO_0004611, EFO_0010351
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	COBLL1 RELB CELSR2 LPA MACF1	1.14e-03	127	181	5	EFO_0008595, EFO_0020947
Disease	free cholesterol to total lipids in small VLDL percentage	COBLL1 CELSR2 LPA DOCK7	1.19e-03	75	181	4	EFO_0022287
Disease	C-reactive protein measurement	DCHS2 CD248 COBLL1 BAAT THUMPD3 APCS RELB IPO9 PXDN CELSR2 AOPEP LPA EEPD1 DOCK7 JAZF1 MACF1 BSN	1.27e-03	1206	181	17	EFO_0004458
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	COBLL1 RELB CELSR2 LPA EEPD1 DOCK7 MACF1	1.27e-03	264	181	7	EFO_0008317, EFO_0020944
Disease	Lung Neoplasms	A2M MPP1 CYP2E1 AZGP1 TEP1 SLC3A2 GJA1	1.30e-03	265	181	7	C0024121
Disease	Pancreatic carcinoma, familial	PALB2 BRCA1	1.31e-03	9	181	2	C2931038
Disease	Malignant neoplasm of lung	A2M MPP1 CYP2E1 AZGP1 TEP1 SLC3A2 GJA1	1.33e-03	266	181	7	C0242379
Disease	sexual dimorphism measurement	USP36 EPPK1 CD248 COBLL1 ZBTB4 FRS3 RELB AOPEP LPA DPEP3 ZNF638 JAZF1 OTUD4 MACF1 BSN TASOR	1.35e-03	1106	181	16	EFO_0021796
Disease	cholesteryl esters to total lipids in very large HDL percentage	CELSR2 LPA DOCK7	1.40e-03	36	181	3	EFO_0022257
Disease	myocardial infarction	COL4A2 TDRKH DCLRE1B IPO9 CELSR2 LPA GPSM1 PDZD2	1.50e-03	350	181	8	EFO_0000612
Disease	cholesteryl esters to total lipids in medium LDL percentage	COBLL1 LPA DOCK7	1.51e-03	37	181	3	EFO_0022252
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	ACACB COBLL1 CELSR2 LPA DOCK7 MACF1	1.51e-03	200	181	6	EFO_0004611, EFO_0020945
Disease	aspirin use measurement	COL4A2 CELSR2 LPA	1.76e-03	39	181	3	EFO_0007013
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	HIVEP1 COBLL1 IPO9 PKHD1 AUTS2 MACF1 PRRC2A PLCE1	1.91e-03	364	181	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	PR domain zinc finger protein 1 measurement	RPSA BSN	1.98e-03	11	181	2	EFO_0801904
Disease	nucleus accumbens volume change measurement	DSCAM MUC16	1.98e-03	11	181	2	EFO_0021493
Disease	Neoplasm of uncertain or unknown behavior of breast	PALB2 BRCA1 HERC2	2.04e-03	41	181	3	C0496956
Disease	Breast adenocarcinoma	PALB2 BRCA1 HERC2	2.04e-03	41	181	3	C0858252
Disease	cholesteryl esters to total lipids in small LDL percentage	COBLL1 LPA DOCK7	2.19e-03	42	181	3	EFO_0022255
Disease	response to methotrexate, serum alanine aminotransferase measurement	LRCH1 MTCL1 PDZD2	2.34e-03	43	181	3	EFO_0004735, GO_0031427
Disease	triglycerides in large LDL measurement	COBLL1 CELSR2 DOCK7	2.34e-03	43	181	3	EFO_0022319
Disease	free cholesterol to total lipids in IDL percentage	CELSR2 LPA DOCK7	2.34e-03	43	181	3	EFO_0022278
Disease	cholesteryl esters to total lipids in small HDL percentage	CELSR2 LPA DOCK7	2.34e-03	43	181	3	EFO_0022254
Disease	free cholesterol to total lipids in very small VLDL percentage	CELSR2 LPA DOCK7	2.34e-03	43	181	3	EFO_0022290
Disease	complement C1q tumor necrosis factor-related protein 1 measurement	PSAP CELSR2	2.37e-03	12	181	2	EFO_0801493
Disease	granulins measurement	PSAP CELSR2	2.37e-03	12	181	2	EFO_0008141
Disease	sleep duration, low density lipoprotein cholesterol measurement	OGDH CELSR2 LPA DOCK7	2.42e-03	91	181	4	EFO_0004611, EFO_0005271
Disease	Alcohol Use Disorder	CYP2E1 BAG3 ADH4	2.50e-03	44	181	3	C0001956
Disease	platelet component distribution width	STARD8 COBLL1 OSER1 SIRPB1 LRCH1 GSK3B RAPGEF3 EPC1 DOCK7 MACF1 SIGLEC1 PRRC2A	2.53e-03	755	181	12	EFO_0007984
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	COBLL1 RELB CELSR2 LPA DOCK7 MACF1	2.56e-03	222	181	6	EFO_0008317, EFO_0020943
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	COBLL1 RELB CELSR2 LPA DOCK7	2.59e-03	153	181	5	EFO_0004611, EFO_0020946
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	COBLL1 RELB CELSR2 LPA DOCK7	2.59e-03	153	181	5	EFO_0004611, EFO_0020944
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	ACACB COBLL1 CELSR2 LPA DOCK7 MACF1	2.67e-03	224	181	6	EFO_0004530, EFO_0008317
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	ACACB COBLL1 RELB CELSR2 LPA DOCK7	2.67e-03	224	181	6	EFO_0004574, EFO_0008317
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	COBLL1 RELB CELSR2 LPA EEPD1 MACF1	2.73e-03	225	181	6	EFO_0008317, EFO_0020947

Protein segments in the cluster

Peptide	Gene	Start	Entry
LAETVAPAVRGSNPH	ESYT1	161	Q9BSJ8
VNSIAPINARHIPRT	EPC1	766	Q9H2F5
ATPVSALVDEPVHIR	BAAT	6	Q14032
RHLAVHPPESLAVVA	ARHGEF10	721	O15013
EHRRTLTPVPQQFSV	ARSH	516	Q5FYA8
AAVSEHRQTLSPVPQ	ARSD	546	P51689
PPKAHEVRIQIIATS	ADH4	31	P08319
ATHPALSRDHQIPVI	CD248	471	Q9HCU0
HFTQALSTVTPRIPE	SPATA5	861	Q8NB90
ALPAETHVVVAAQPT	ACTL9	361	Q8TC94
PAIAIAVHSQDVSIP	COL4A2	1596	P08572
TSSNVHVPAAVPLVR	ATF2	236	P15336
SATTQEIIPHRVFAP	AOPEP	391	Q8N6M6
VLPAIPSQRRHSTAA	ANKRD55	586	Q3KP44
PTLPDVTIRNVSRHI	LINC00469	6	Q8N7U9
SIVPALEIANAHRKP	HSPD1	256	P10809
QAVAATLATPPDHVV	CELSR2	1151	Q9HCU4
QIHLPVVQSVASPAA	ATXN1	551	P54253
PALVLPSRQEAAHQI	DCLRE1B	151	Q9H816
AAPASPEQIIVHALS	DMTF1	536	Q9Y222
VRVSPHASLQELAPI	COBLL1	161	Q53SF7
IPPHQSDENSRVTAL	COBLL1	371	Q53SF7
HLATAVPLTPRVNIN	EEPD1	126	Q7L9B9
EIPLTVTHPVVRNAL	A2M	1111	P01023
LPPAQVLDAHTRVVQ	NWD1	401	Q149M9
SNLRELPIAPSHVIE	RBM33	706	Q96EV2
AHPPTQILNRERETV	OTUD4	961	Q01804
QEAQPRPSLTTAHAE	RAB44	771	Q7Z6P3
DSPEAAVAVVHALPR	ARHGAP39	991	Q9C0H5
ADVHRQIAIVFKTPP	RELB	351	Q01201
ITLVPSNLPHEATRD	CYP2E1	361	P05181
VLHSPPAVRRVDSIT	MTCL1	1511	Q9Y4B5
HFLAVNRVIPTNVPE	MEN1	46	O00255
LSRPTAAVQLPRATH	MRNIP	276	Q6NTE8
AAVQLPRATHPVTSG	MRNIP	281	Q6NTE8
VIPPVAQATVNFRIH	PM20D1	351	Q6GTS8
IIQVDPSRIHVPSSL	PEX10	76	O60683
RHQKIVEEAPATIAP	ACACB	526	O00763
SLRTQDSVPPLHRQV	CAPN15	1016	O75808
QAALLHVSAPRTARP	CFAP99	591	D6REC4
DVPAQPITTTFLERH	MAOB	471	P27338
HQPLRSLPSVRQDVS	HECW2	786	Q9P2P5
AALTIQESPVHILSP	OBSL1	706	O75147
QESPVHILSPQDRVS	OBSL1	711	O75147
VVPVSSHRNPRLDLA	NUP210	776	Q8TEM1
PSERVVSATHQVFLP	RELCH	691	Q9P260
REKIHPSSNTPVVNV	MUC16	8636	Q8WXI7
NAPVNTRLAIEHPAV	PCDH20	221	Q8N6Y1
ARLHTKPSQAPAVEV	NOP53	226	Q9NZM5
VPLPRSLHTASVIGN	HCFC2	241	Q9Y5Z7
LDLPVDAVVTLSQHP	HOGA1	176	Q86XE5
ASRLQAPVLVAAPHS	LPCAT4	116	Q643R3
AHARTPVLQVHPLES	FOXP3	111	Q9BZS1
ALRKEHVNPPAEVST	MGAT4B	391	Q9UQ53
PSHIIPVRVADAAKN	ALAS1	526	P13196
LPAPNTVTAVTAAHI	LATS2	426	Q9NRM7
ADVRVHVPRTSIPRA	GPSM1	476	Q86YR5
SSEATTPVAVQHIRP	HERC2	2431	O95714
TPSVHEPVLFQTARD	HERC2	3331	O95714
DPRQITPSLETHLVQ	MTO1	411	Q9Y2Z2
VVPLAVENLPSLSAH	FRMD8	41	Q9BZ67
HSVLNRSPPELVAEI	GALNT10	166	Q86SR1
HAPPQIASSAPTVRV	HMCN2	881	Q8NDA2
EDARLHTVNVLVPPT	HMCN2	3306	Q8NDA2
VLHVSENPVPLTVRV	LRRC47	311	Q8N1G4
VVPLAVENLPSLRAH	FRMD8P1	41	Q9BZ68
TINFHPPVSAEIIRK	JAZF1	226	Q86VZ6
RQKNEVTLSIPVDHP	KCNH5	691	Q8NCM2
LPRVSPAIHITAATD	BSN	2681	Q9UPA5
LTSVNHRSPLQAVEP	DYNC2I1	756	Q8WVS4
HRSPLQAVEPISTSV	DYNC2I1	761	Q8WVS4
QPPTLAEAVKIERTH	C9orf131	731	Q5VYM1
LTAHQVDRIPVAACP	PLXNB3	461	Q9ULL4
RLASHVAADTAQPRP	PDZD2	2056	O15018
VEPPQDSHSRKTVLI	PRPH	426	P41219
LVELQQRVTHASPPS	NAV3	196	Q8IVL0
NATRVENVHSPLPIS	MRTFB	481	Q9ULH7
DVAARPGTVPHTLLQ	AUTS2	616	Q8WXX7
PPSPDVLQAATHRVV	PHRF1	971	Q9P1Y6
VLQAATHRVVELRPP	PHRF1	976	Q9P1Y6
TRALIAQLPSPAIDH	MACF1	1926	O94854
IIHQRTNTVPFDLVP	MUL1	116	Q969V5
VNHIRPRSVASIHVP	LRCH1	616	Q9Y2L9
AEVPPDTRNVVRASH	TUBGCP5	421	Q96RT8
PEPAALRAHTVVQLD	LRFN3	601	Q9BTN0
VLVEHVVPASEPAAR	NKD2	301	Q969F2
TPEQALSHPEVQRRL	IQGAP3	1101	Q86VI3
PPRSSVIHLQVRVLD	DCHS2	1911	Q6V1P9
DHVTQNTLEDVPLRP	PRTG	506	Q2VWP7
NPARSPVTEIRTHLL	PALB2	186	Q86YC2
PTDVARVVNAPIFHV	OGDH	461	Q02218
HALELVVSRNLSPPN	BRCA1	621	P38398
TVVLPASHRRPVSAN	FHAD1	156	B1AJZ9
PRASAISHPLRIAVT	CD101	656	Q93033
VLVPLAVAPQESHRT	DACT2	571	Q5SW24
HVPPAAITTLARSAI	DOCK7	316	Q96N67
PRPIVNHAETSRLNI	CRY2	486	Q49AN0
SIPHTVTNLELPVRE	CPLANE1	2596	Q9H799
HQVLRIDVTLSPRDP	GALNT5	421	Q7Z7M9
PVIITRNSHPAELDL	FRS3	116	O43559
AVDQPDVVQRSHTVP	ARFGEF3	556	Q5TH69
VPPSNVEAIAEHAVL	CMYA5	616	Q8N3K9
HELQPLAIVDQRPSS	GJA1	351	P17302
ILIPPHARIQAAAST	GSK3B	376	P49841
VINARETVPASHAPS	GGT5	106	P36269
AVVSIPRQLPGSHSE	SLC3A2	11	P08195
HSEAAPTEQTPVVRQ	LPA	1601	P08519
SAVPVANSVLVVAPH	MS4A8	6	Q9BY19
HETQPPSVRISAVRA	IPO9	526	Q96P70
ARLTVNAPPVVTALH	KIRREL2	391	Q6UWL6
LSIARAVQEVHPSPV	KLF12	261	Q9Y4X4
PGPRSSLDQHVAAVV	CUL9	671	Q8IWT3
VNLRNRVSAIHEVPP	CUL9	2311	Q8IWT3
TVVRRPNLHPSFIAI	CSN3	106	P07498
SRPEAVSHPLNTVTE	MPP1	31	Q00013
ATHLEVTKQPTNRVP	DPEP3	446	Q9H4B8
QTRGAPVSDPIHLSV	FCRLB	86	Q6BAA4
LPVPLRAHSTLQDEA	COLGALT1	291	Q8NBJ5
ISIPVIHEQNVTRPA	BAG3	206	O95817
HDQVLPTPNASSRVI	POLI	41	Q9UNA4
PTPNASSRVIVHVDL	POLI	46	Q9UNA4
IFNVHPAPTRKIAVA	RUBCN	701	Q92622
AVPTAAPRNVVVHGA	SDK2	1621	Q58EX2
RQLRVATVPPSLQHE	PRRT3	161	Q5FWE3
PVSLPAAVDTHRQTL	PKD1L1	726	Q8TDX9
VLHAPVPTTARARLS	KIFC2	796	Q96AC6
EPREHIIPVVVSHNA	CDH16	736	O75309
APHVQASVRATPVTR	FAM8A1	206	Q9UBU6
VHVHTNAARQPELPT	PPM1F	211	P49593
QSLESLHRIPSAPVI	OSBPL7	216	Q9BZF2
DVHVQIETSPPARNL	IL4I1	296	Q96RQ9
PHVINPVESRLGSSA	PIGS	301	Q96S52
AAVEHQSQLIVRVPP	DSCAM	676	O60469
LLVVTDPRADHQPLT	RPSA	121	P08865
LHSITVPQDPAVLRQ	WARS2	76	Q9UGM6
PVQSHRTSEISIPAD	UTRN	2216	P46939
VNISVLPSPAHAFRA	SIGLEC15	171	Q6ZMC9
EAAVSTEEPRINLPH	PTAR1	276	Q7Z6K3
VRAFIVRSHVPASQP	TMEM132E	126	Q6IEE7
ARERNVIVHTNPDPS	NHS	421	Q6T4R5
VHDVSPEQPRTVIKA	PLCE1	2141	Q9P212
HETIASLRAQSPPVK	KIFC3	241	Q9BVG8
ADSPSAPVNVTVRHL	FNDC5	31	Q8NAU1
EVPSAVPVVHQVSRA	EPHB6	486	O15197
VIDPVHSHRVPVDVA	EPPK1	5016	P58107
PPSSSAVFRLDQVIH	PRRC2A	1456	P48634
DVSHLIRRPISVNPN	TANC2	1746	Q9HCD6
HFRIQLPNTVISDVP	PKHD1	791	P08F94
HPTSVHALRPADIQV	PLB1	726	Q6P1J6
SVPTSVHQLRPADIK	PLB1	1081	Q6P1J6
ISQPAHVALIQAVAP	SRCAP	1251	Q6ZRS2
NHTGAVVEPLRTSVP	OSER1	141	Q9NX31
STEVAAPPAVVLHRV	STARD8	866	Q92502
IASNPLERHVIPVSS	TASOR	1111	Q9UK61
VVSGPAVRATPEHTV	SIRPB1	151	O00241
RPDHSVLTLQLPVTA	RAPGEF3	566	O95398
VISTVRPQLCHSEPT	TBC1D17	91	Q9HA65
RPPKEVHLAQLTAAT	VPS13A	606	Q96RL7
VTPHVVVPAEEALAR	RBP3	1211	P10745
HSAETRVPRKQPISV	TDRKH	206	Q9Y2W6
VLPALQARAAPHRIS	TEP1	921	Q99973
SARIRPTAVTLEHVP	SUN2	616	Q9UH99
AVPSAAHQEAPVTSR	SPEG	2776	Q15772
PRESVTDHVNLITPL	APCS	31	P02743
PSSPAVRDLVERHQA	TRAPPC14	496	Q8WVR3
SPQQHRLFRVLETPV	TMEM94	236	Q12767
RAEPSLHQVVLQPSR	IGSF9B	1186	Q9UPX0
IPVESNSPRHRSLLQ	SLC39A7	156	Q92504
TRLPEASQAHVRVSP	TONSL	706	Q96HA7
HLLLEAVPAVAPQTS	PXDN	51	Q92626
HLTVQPRVTPVFASI	PXDN	516	Q92626
DTLVPAHPALVNAIV	UBL7	176	Q96S82
ADVHLVPRTTKEVPA	TMPRSS9	6	Q7Z410
EVTDPSHAPAVLRQL	ZBTB4	6	Q9P1Z0
RLPHQPVTAITRVSD	SMTNL2	191	Q2TAL5
EIDGVPTHPTALNRV	TMCC1	91	O94876
HREPVPLKSISVSVN	VWA5A	11	O00534
AHSIPLPNVTVRDAT	SIGLEC1	1131	Q9BZZ2
EPVPTLAFTHVARAQ	SIGLEC1	1491	Q9BZZ2
KVTAQPVERSAFPVH	PKHD1L1	4061	Q86WI1
TRLPALTVHVTQPKD	PSAP	391	P07602
DLVIHRTSVPAPLNS	GTF3C4	101	Q9UKN8
PVAHIRPLPTTVQAA	PRR33	76	A8MZF0
VLIRTPQAFVHPSEQ	THUMPD3	481	Q9BV44
LDRQDPPSVVVTSHQ	AZGP1	201	P25311
PAVIFTKVVSPENLH	VPS13B	1701	Q7Z7G8
TLSEDPSPRVIIHNR	VPS13B	3246	Q7Z7G8
QPDVALHARPATSTV	ZNF362	101	Q5T0B9
AAQARVRDAPAVTHP	ZNF16	26	P17020
VTQLEAAEHLQSRPP	TEX28	311	O15482
VGPVPARALHNVTAE	ITFG1	26	Q8TB96
NATAVHADLPVPDII	ZYG11A	131	Q6WRX3
EHLIASSDLPPSQRV	ZNF329	71	Q86UD4
VSSNISEDPVPVKRH	VIP	111	P01282
TALPRRQPTVHFSDV	HIVEP1	2691	P15822
LISSVSQQERIPHEP	ZNF638	341	Q14966
ETRLPQHIREATAAP	USP36	826	Q9P275
APVSRQVPASHDSEL	UBXN11	61	Q5T124
VQTLRPHPAEATLQR	UBXN11	111	Q5T124
QPTIERVALNSREPH	WDR43	356	Q15061
LAAARAPPATQDVHV	ZNF628	666	Q5EBL2
ADLVRPSPLTLHTVQ	TPP1	86	O14773